Closure of the patent ductus arteriosus with ibuprofen and other non-steroidal anti-inflammatory medications in neonates

Eastern Journal of Medicine

Volumn 15, Issue 4, 2010, Pages 139-145

  Wong, Abdul Rahim ^a   Ramli, Noraida ^a   Zain, Mohd Rizal Mohd ^a   Mokhtar, Sharifah Ainon Ismail ^b   Van Rostenberghe, Hans ^a   Rasool, Aida Hanum Ghulam ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^b HOSPITAL PULAU PINANG   (Malaysia)

Author keywords

Ibuprofen; Patent ductus arteriosus; Premature neonates

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IBUPROFEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SULINDAC;

BLOOD ANALYSIS; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DUCTUS ARTERIOSUS OBLITERATION; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPONATREMIA; INTESTINE PERFORATION; KIDNEY DYSFUNCTION; MORBIDITY; MORTALITY; NECROTIZING ENTEROCOLITIS; OLIGURIA; PATENT DUCTUS ARTERIOSUS; PILOT STUDY; PREMATURITY; PULMONARY HYPERTENSION; REVIEW; SIDE EFFECT; THORACOTOMY; THROMBOCYTE DYSFUNCTION; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 79251515015     PISSN: 13010883     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Clyman RI. Recommendations for the postnatal use of indomethacin: An analysis of four separate treatment strategies. The Journal of Pediatrics 1996; 128: 601-607.
2. Kumar RK, Yu VYH. Prolonged low-dose indomethacin therapy for patent ductus arteriosus in very low birthweight infants. J Paediatr Child Health 1997; 33: 38-41.
3. Brooks JM, Travadi JN, Patole SK, Doherty DA, Simmer K. Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Retal Neonatal Ed 2005; 90: F235-F239.
4. Clyman RI, Chome N. Patent ductus arteriosus: Evidence for and against treatment. J Pediatrics 2007; 150: 216-219.
5. Mehta SK, Younoszai A, Pietz J, Achanti BP. Pharmacological closure of the patent ductus arteriosus. Images Paediatr Cardiol 2003; 14: 1-15.
6. Raval MV, Laughon MM, Bose CL, Phillips JD. Patent ductus arteriosus ligation in premature infants: who really benefits, and what cost? Journal of Pediatric Surgery 2007; 42: 69-75.
7. Kabra NS, Schmidt B, Roberts RS, et al. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: Results from the trial of indomethacin prophylaxis in preterms. J Pediatr 2007; 150: 229-34.
8. Schmidt B, Roberts RS, Fanaroff A, et al. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: Further analyses from the trial of indomethacin phrophylaxis in preterms (TIPP). J Pediatr 2006; 148: 730-734.
9. Clyman RI, Saha S, Jobe A, Oh W. Indomethacin prophylaxis for preterm infants: The impact of 2 multicentre randomized controlled trials on clinical practice. J Pediatr 2007; 150: 46-50.
10. Malviya MN, Ohlsson A, Shah SS. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD003951. DOI:10. 1002/14651858. CD003951. pub2.
11. Fuji A, Brown E, Mirochnick M, O'Brien S, Kaufman G. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus. J Perinatol 2002; 22: 535-540.
12. Grosfeld JL, Chaet M, Molinari F, et al. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann. Surg 1996; 224: 350-357.
13. Patel J, Marks KA, Roberts I, Azzopardi D, Edwards AD. Ibuprofen treatment of patent ductus arteriosus. The Lancet 1995; 346: 255.
14. Varvarigou A, Bardin CL, Beharry K, et al. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996; 275: 539-544.
15. Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ. Treatment of patent ductus arteriosus with ibuprofen. Archives of Disease in childhood 1997; 76: F179-F184.
16. Van Overmeire B, Smets K, Lecoutere D, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Eng J Med 2000; 343: 674-681.
17. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birthweight infants. Cochrane Database of Systematic Reviews 2008, Issue1. Art.No.: CD003481.DOI:10.1002/14651858.CD003481.pub 3.
18. Ng PC, So KW, Fok TF, et al. Comparing sulindac with indomethacin for closure of ductus arteriosus in preterm infants. J Paediatr Child Health 1997; 33: 324-332.
19. Lesko SM, Mitchell AA. Renal function after short-term ibuprofen use in infants and children. Pediatrics 1997; 100: 954-957.
20. Walson PD. Comparison of multidose ibuprofen vs. acetaminophen therapy in febrile children. Am J Dis Child 1992; 146: 626-632.
21. Aranda JV, Varvarigou A, Beharry K, et al. Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant. Acta Paediatr 1997; 86: 289-293.
22. Van Overmeire B, Tuow D, Schepens PJC, Kearns GL, van den Anker JN. Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther 2001; 70: 336-343.
23. Sharma PK, Garg SK, Narang A. Pharmacokinetics of oral ibuprofen in premature infants. J Clin Pharmacol 2003; 43: 968-973.
24. Hirt D, Van Overmeire B, Treluyer JM, et al. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. Br J Clin Pharmacol 2008; 65: 629-636.
25. Hariprasad P, Sundarrajan V, Srimathy G, Suthagar B, Ramadevi BS. Oral ibuprofen for closure of hemodynamically significant PDA in premature neonates. Indian Pediatrics 2002; 39: 99-100.
26. Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. J Med Assoc Thai 2002; 85 Suppl 4: S1252-S1258.
27. Chotigeat U, Jirapa K, Layangkool TA. Comparison of oral ibuprofen and intravenous indomethacin for closure of PDA in pre-term infants. J Med Assoc Thai 2003; 86 Suppl 3: S563-S569.
28. Heyman E, Morag I, Batash D, et al. Abstract. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: A Pilot Study. Pediatrics 2003; 112: e354.
29. Cherif A, Khrouf N, Jabnoun S, et al. Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. Pediatrics 2008; 122: e1256-e1261.
30. Amoozgar H, Ghodstehrani M, Pishva N. Oral ibuprofen and ductus arteriosus closure in fullterm neonates: A prospective case-control study. Pediatr Cardiol DOI 10.1007/s00246-009-9542-y (publication online 20 October 2009).